Suppr超能文献

[利尿剂]

[Diuretics].

作者信息

Schwartz J, Bloch R, Imbs J L, Spach M O

出版信息

Pathol Biol (Paris). 1986 Sep;34(7):861-85.

PMID:3537932
Abstract

Microaspiration techniques and clearance studies have shown that reabsorption of filtered sodium approximates 65% in the proximal tubule, 25 to 30% in the ascending limb of the loop of Henle and 5 to 10% in the dilution segment. Reabsorption in the Henle loop is of special significance as it governs the process of dilution-concentration of urine. Moreover, inhibition of sodium reabsorption in the loop of Henle necessarily produces a substantial loss of sodium since only a fairly small fraction of urinary sodium is reabsorbed beyond the Henle loop (dilution segment, distal tubule). Excretion of water and electrolytes is regulated by humoral factors, such as the renin-angiotensin-aldosterone system, some prostaglandins and certain kinins. Factors that promote excretion of sodium, produced in particular by the myocardium, have recently been demonstrated. The correlation between blood pressure and salt has been substantiated by many findings. Diuretics are commonly used to treat high blood pressure as well as edema. Recent evidence indicates that sodium transport is altered in idiopathic hypertension, at least in red blood cells. Clinical trials of diuretics are designed to localize the drug's action and quantify its saluretic activity (evaluation of potency and effectiveness--single doses, sustained treatment). Furthermore, the minimal efficient antihypertensive dosage should be determined. Diuretics can be divided into two groups according to whether they produce an increase or decrease in serum potassium. Diuretics that are capable of producing hypokalemia belong to two main families. One consists of the Henle loop diuretics that interfere with the mechanisms of dilution-concentration of urine. Action of these drugs is potent and short-lived. For instance, following a single dose of furosemide, excretion of sodium can reach 25-30% of filtered sodium; renal blood flow increases; CH2O and TCH2O decrease. With furosemide, induction of diuresis is rapid (within a few minutes after IV injection and 20 mn after oral ingestion); elimination half-life is 50 mn; absolute bioavailability is 50-70%; 95% of the drug is bound to plasma proteins; elimination is mainly through the kidneys. Other Henle loop diuretics include ethacrynic acid, whose elimination half-life is less than one hour; bumetanide, which is 40 times more potent than furosemide; muzolimine, whose action is more lasting despite the fact that only 65% of the drug is bound to plasma proteins; and ozolinone, which has a saliuretic action comparable to that of furosemide and in addition exerts a direct vasodilating effect.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

微量吸入技术和清除率研究表明,滤过钠在近端小管的重吸收率约为65%,在髓袢升支为25%至30%,在稀释段为5%至10%。髓袢的重吸收具有特殊意义,因为它控制着尿液的稀释 - 浓缩过程。此外,抑制髓袢中的钠重吸收必然会导致大量钠流失,因为在髓袢之后(稀释段、远端小管)只有相当小部分的尿钠被重吸收。水和电解质的排泄受体液因素调节,如肾素 - 血管紧张素 - 醛固酮系统、一些前列腺素和某些激肽。最近已证实,特别是由心肌产生的促进钠排泄的因素。血压与盐之间的相关性已得到许多研究结果的证实。利尿剂常用于治疗高血压和水肿。最近的证据表明,特发性高血压中钠转运发生改变,至少在红细胞中如此。利尿剂的临床试验旨在确定药物的作用部位并量化其利钠活性(评估效力和有效性——单剂量、持续治疗)。此外,应确定最小有效降压剂量。利尿剂可根据其是否导致血清钾升高或降低分为两组。能够导致低钾血症的利尿剂主要属于两个类别。一类是髓袢利尿剂,它们干扰尿液的稀释 - 浓缩机制。这些药物作用强大但持续时间短。例如,单次服用呋塞米后,钠排泄量可达到滤过钠的25% - 30%;肾血流量增加;自由水清除率(CH2O)和肾小管对水的重吸收率(TCH2O)降低。使用呋塞米时,利尿作用迅速(静脉注射后几分钟内,口服后20分钟);消除半衰期为50分钟;绝对生物利用度为50% - 70%;95%的药物与血浆蛋白结合;主要通过肾脏排泄。其他髓袢利尿剂包括依他尼酸,其消除半衰期小于1小时;布美他尼,其效力比呋塞米强40倍;莫唑胺,尽管只有65%的药物与血浆蛋白结合,但其作用更持久;以及奥索利酮,其利钠作用与呋塞米相当,此外还具有直接血管舒张作用。(摘要截断于400字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验